Skip to content

European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients

Patient Perception of Symptom Variability. A Cross-sectional Study of Patients With Severe COPD.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00722267
Enrollment
7400
Registered
2008-07-25
Start date
2008-07-31
Completion date
2009-02-28
Last updated
2020-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Keywords

severe COPD, COPD symptoms, variability of symptoms, patient's perception

Brief summary

This study is investigating how patients with severe stable state COPD perceive the variability of their symptoms throughout the day, the week and the year; the impact of these variations on their daily activities or sleep quality and how they deal with their treatments. For this purpose patients will be asked to answer a questionnaire over the phone

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Outpatients with a diagnosis of COPD * FEV1\<50% and FEV1/FVC\<0.7 according to lung function data in medical records. * Smoker or ex-smoker \> 10 pack-years * Informed consent obtained

Exclusion criteria

* Ongoing exacerbation of COPD or within the previous 3 months * Any other significant respiratory disease (including asthma and allergic rhinitis)

Design outcomes

Primary

MeasureTime frame
Patient's perception of the variability of symptoms due to severe stable state COPD throughout the day, the week and the yearOnce

Secondary

MeasureTime frame
Describe how patient use their COPD treatmentOnce
Factors that may influence the patient's perception of symptom variabilityOnce
Impact of symptoms (and variability of symptoms) on the patient's morning & daily living activities and sleep quality.Once

Countries

Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Turkey (Türkiye), United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026